知镜 Cognispect · 医学文献与研究工作台

Radiation therapy and overall survival in male breast cancer: a multicenter analysis of 302 patients.

Colciago RR, Franco P, Giandini C, Carnevale MG, Di Cosimo S, Minicozzi P, Manitto R, Ferrara E, Fozza A, Coco A, Spoto R, Dominici L, Marino L, Lucidi S, De Rose F, Bonzano E, Prisco A, Meduri B, Bertini N, Meattini I, Verderio P, De Santis MC.
La Radiologia medica · 2026-09-28 · PMID 42804144

文献摘要

Aim This multicenter study aimed to assess the efficacy and the prognostic role of adjuvant radiation therapy and other factors in a cohort of male breast cancer patients (MaBC) treated in 10 Italian centers within the Clinical Oncology Breast Cancer Group. Methods This retrospective study included patients diagnosed with MaBC between 2005 and 2023. Demographic, clinical, tumor, and treatment data were retrieved from medical records. Information on treatment-related acute and late adverse events was also collected. Disease-free survival (DFS) was calculated from surgery to recurrence or last follow-up visit, overall survival (OS) from diagnosis to death or last follow-up visit. Results Overall, 302 patients were included (median age 69). Most were diagnosed with stage I-IIIa (75%; vs 25% stage IIIb-IV), invasive ductal carcinoma (88%) and luminal-like tumors (88%). Nearly all patients underwent mastectomy (96%), 31% received adjuvant chemotherapy, 83% endocrine therapy (mainly tamoxifen), and 33% radiation therapy. At a median follow-up of 79 months, DFS and OS were significantly associated, among others, with stage (p Conclusions This large retrospective cohort study showed that MaBC patients treated with multi-modality therapies achieved favorable outcomes. Specifically, radiation therapy significantly improved survival in advanced stages with low incidence of late adverse events further supporting its role in daily clinical practice.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。